Burçak Özeş

574 total citations
12 papers, 185 citations indexed

About

Burçak Özeş is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Burçak Özeş has authored 12 papers receiving a total of 185 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 3 papers in Neurology. Recurrent topics in Burçak Özeş's work include Hereditary Neurological Disorders (6 papers), Neurological diseases and metabolism (3 papers) and Muscle Physiology and Disorders (3 papers). Burçak Özeş is often cited by papers focused on Hereditary Neurological Disorders (6 papers), Neurological diseases and metabolism (3 papers) and Muscle Physiology and Disorders (3 papers). Burçak Özeş collaborates with scholars based in United States, Türkiye and Germany. Burçak Özeş's co-authors include Zarife Sahenk, Esra Battaloğlu, Lei Chen, Darren Murrey, Jerry R. Mendell, Rebecca Schüle, Jennifer Reichbauer, Dagmar Timmann, Michael Gonzalez and Musa Onar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Brain Research.

In The Last Decade

Burçak Özeş

12 papers receiving 184 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Burçak Özeş United States 8 107 88 39 39 30 12 185
Tomoya Nishimura Japan 8 111 1.0× 109 1.2× 62 1.6× 50 1.3× 33 1.1× 17 246
Lea Papić Austria 7 133 1.2× 76 0.9× 25 0.6× 66 1.7× 69 2.3× 7 209
Breanne L. Harty United States 9 179 1.7× 159 1.8× 28 0.7× 30 0.8× 55 1.8× 10 336
María Jesús Sobrido Spain 8 100 0.9× 158 1.8× 53 1.4× 29 0.7× 13 0.4× 20 224
Elisa Sarto Italy 8 139 1.3× 112 1.3× 38 1.0× 73 1.9× 34 1.1× 12 219
Rolf Schiff United States 12 143 1.3× 142 1.6× 41 1.1× 50 1.3× 45 1.5× 20 345
Daliya Kancheva Belgium 9 38 0.4× 102 1.2× 17 0.4× 90 2.3× 34 1.1× 14 269
Jennifer Stocksdale United States 5 83 0.8× 179 2.0× 51 1.3× 103 2.6× 16 0.5× 6 287
Dorothée Bleckmann Switzerland 8 172 1.6× 228 2.6× 81 2.1× 31 0.8× 38 1.3× 9 334
Dominic Luciano United States 3 123 1.1× 160 1.8× 15 0.4× 75 1.9× 21 0.7× 5 326

Countries citing papers authored by Burçak Özeş

Since Specialization
Citations

This map shows the geographic impact of Burçak Özeş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Burçak Özeş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Burçak Özeş more than expected).

Fields of papers citing papers by Burçak Özeş

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Burçak Özeş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Burçak Özeş. The network helps show where Burçak Özeş may publish in the future.

Co-authorship network of co-authors of Burçak Özeş

This figure shows the co-authorship network connecting the top 25 collaborators of Burçak Özeş. A scholar is included among the top collaborators of Burçak Özeş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Burçak Özeş. Burçak Özeş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Tong, Lingying, et al.. (2025). AAV1.NT3 gene therapy mitigates the severity of autoimmune encephalomyelitis in the mouse model for multiple sclerosis. Gene Therapy. 32(4). 410–420. 1 indexed citations
2.
Özeş, Burçak, et al.. (2024). AAV1.tMCK.NT-3 gene therapy improves phenotype in Sh3tc2−/− mouse model of Charcot–Marie–Tooth Type 4C. Brain Communications. 6(6). fcae394–fcae394. 1 indexed citations
3.
Özeş, Burçak, et al.. (2023). AAV1.NT-3 gene therapy prevents age-related sarcopenia. Aging. 15(5). 1306–1329. 14 indexed citations
4.
Özeş, Burçak, et al.. (2023). AAV1.NT‐3 gene therapy in the SOD1KO mouse model of accelerated sarcopenia. Journal of Cachexia Sarcopenia and Muscle. 14(5). 2204–2215. 3 indexed citations
5.
Özeş, Burçak, et al.. (2021). AAV1.NT-3 gene therapy in a CMT2D model: phenotypic improvements in GarsP278KY/+ mice. Brain Communications. 3(4). fcab252–fcab252. 19 indexed citations
6.
Sahenk, Zarife, Burçak Özeş, Darren Murrey, et al.. (2021). Systemic delivery of AAVrh74.tMCK.hCAPN3 rescues the phenotype in a mouse model for LGMD2A/R1. Molecular Therapy — Methods & Clinical Development. 22. 401–414. 10 indexed citations
7.
Özeş, Burçak, Lei Chen, Shasha Bai, et al.. (2021). AAV1.NT-3 gene therapy for X-linked Charcot–Marie–Tooth neuropathy type 1. Gene Therapy. 29(3-4). 127–137. 31 indexed citations
8.
Sahenk, Zarife & Burçak Özeş. (2019). Gene therapy to promote regeneration in Charcot-Marie-Tooth disease. Brain Research. 1727. 146533–146533. 27 indexed citations
9.
Saatci, Özge, Burçak Özeş, İpek Çoban, et al.. (2018). SIK2 attenuates proliferation and survival of breast cancer cells with simultaneous perturbation of MAPK and PI3K/Akt pathways. Oncotarget. 9(31). 21876–21892. 22 indexed citations
10.
Bayrak, Ayşe Oytun, et al.. (2014). Ultrasonographic findings in hereditary neuropathy with liability to pressure palsies. Neurological Research. 37(2). 106–111. 15 indexed citations
11.
Caballero-Oteyza, Andrés, Esra Battaloğlu, Tobias Lindig, et al.. (2014). Motor protein mutations cause a new form of hereditary spastic paraplegia. Neurology. 82(22). 2007–2016. 40 indexed citations
12.
Özeş, Burçak, et al.. (2012). TDP-43 Proteinopatileri: Nörodejeneratif Konformasyon Bozukluğu Hastalıklarında Yeni Bir Oyuncu. SHILAP Revista de lepidopterología. 18(1). 1–10. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026